Y-Intercept (HK)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Y-Intercept (HK)’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,578	Closed	-$769K	–	1836
2023 Q1	$769K	Buy	21,578 +14,200	+192%	+$515K	0.09%	343
2022 Q4	$271K	Sell	7,378 -29,938	-80%	-$1.18M	0.04%	708
2022 Q3	$1.76M	Buy	+37,316	New	+$2.41M	0.18%	169
2021 Q3	–	Sell	-6,024	Closed	-$539K	–	981
2021 Q2	$539K	Buy	+6,024	New	+$509K	0.14%	248

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Y-Intercept (HK)'s SYNH Position: Q2 2023 in Review

Y-Intercept (HK) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 21,578 shares — an estimated $769K sold.

Y-Intercept (HK) first reported a position in SYNH in Q2 2021 and held it in 4 quarters. The position peaked at $1.76M in Q3 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Y-Intercept (HK) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Y-Intercept (HK) sold 21,578 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $769K.
Y-Intercept (HK) first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
Y-Intercept (HK)'s Syneos Health, Inc. Class A Common Stock position peaked at $1.76M in Q3 2022.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.